Irinotecan

Print | Download pdf
Stock Status : <%stockStatus%>

<%deliveryStatus%>

Catalogue number: PA 09 15000
Chemical name: Irinotecan

CAS Number:

97682-44-5
Similar Products:
136572-09-3(Irinotecan HCl Trihydrate - API (HCl Trihydrate));100286-90-6(Hydrochloride salt)
Category: chiral standards,enzyme inhibitors,pharmaceutical standards,intermediates,Fine Chemicals
Synonyms:

(S)-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo1H-pyrano[3',4':6,7]-indolizino[1,2-b]quinolin-9-yl-[1,4'bipiperidine]-1'-carboxylate (USP);
Molecular form: C33H38N4O6
Appearance: NA
Mol. Weight: 586.68
Storage: 2-8°C Refrigerator
Shipping Conditions: Ambient
Applications: Irinotecan main use is in colon cancer, in particular, in combination with other chemotherapy agents. This includes the regimen FOLFIRI, which consists of infusional 5-fluorouracil, leucovorin, and irinotecan.

Irinotecan

97682-44-5
| Sample COA MSDS

Enquire for Irinotecan

I accept terms and conditions

Order Product

Related Products

86639-52-3

Irinotecan Related Compound B ((S)-4,11-diethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b] (1347631)
NA

Irinotecan Related Compound D ((R)-9-[(1,4'-Bipiperidine)-1'-carbonyloxy]-4,11-diethyl-3,4,12,14-te (1347653)
185304-41-0

(S)-12-Ethyl-8-(hydroxymethyl)-7-(1-hydroxypropyl)-9-oxo-9,11-dihydroindolizino[1,2-b]quinolin-2-yl [1,4'-bipiperidine]-1'-carboxylate
136572-09-3

Irinotecan for system suitability 2 (Y0001833)
19685-09-7

Irinotecan Related Compound A ((S)-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quino (1347610)

View More

EVENTS

Search by Keywords – Buy 97682-44-5 | Purchase 97682-44-5 | Order 97682-44-5 | Enquire 97682-44-5 | Price of 97682-44-5 | 97682-44-5 Cost | 97682-44-5 Supplier | 97682-44-5 Distributor | 97682-44-5 Manufacturer | 97682-44-5 Exporter

Tools

Calculators

Normality Dilution Mass molarity
Periodic Table- Pharmaffiliates

Periodic Table

Ask A Scientist-Pharmaffiliates

Ask a Scientist
General Help

General Help

cart bucket

×
Proceed

wishlist

×
Proceed